BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19465947)

  • 1. Colon cancer management in New Zealand: 1996-2003.
    Cunningham R; Sarfati D; Hill S; Dennett E; O'Donnell A
    N Z Med J; 2009 May; 122(1294):51-60. PubMed ID: 19465947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary treatment of colorectal cancer in New Zealand: survival rates from 1997-2002.
    Keating J; Yong D; Cutler G; Johnston J
    N Z Med J; 2006 Sep; 119(1242):U2238. PubMed ID: 16998579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnicity and management of colon cancer in New Zealand: do indigenous patients get a worse deal?
    Hill S; Sarfati D; Blakely T; Robson B; Purdie G; Dennett E; Cormack D; Dew K; Ayanian JZ; Kawachi I
    Cancer; 2010 Jul; 116(13):3205-14. PubMed ID: 20564634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study.
    Sjövall A; Järv V; Blomqvist L; Singnomklao T; Cedermark B; Glimelius B; Holm T
    Eur J Surg Oncol; 2004 Oct; 30(8):834-41. PubMed ID: 15336728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons for failure to diagnose colorectal carcinoma at colonoscopy.
    Leaper M; Johnston MJ; Barclay M; Dobbs BR; Frizelle FA
    Endoscopy; 2004 Jun; 36(6):499-503. PubMed ID: 15202045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services.
    Barton MB; Gabriel GS; Miles S
    ANZ J Surg; 2004 Jun; 74(6):406-12. PubMed ID: 15191469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration.
    Karoui M; Charachon A; Delbaldo C; Loriau J; Laurent A; Sobhani I; Tran Van Nhieu J; Delchier JC; Fagniez PL; Piedbois P; Cherqui D
    Arch Surg; 2007 Jul; 142(7):619-23; discussion 623. PubMed ID: 17638798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma.
    Lee HY; Choi HJ; Park KJ; Shin JS; Kwon HC; Roh MS; Kim C
    Ann Surg Oncol; 2007 May; 14(5):1712-7. PubMed ID: 17253102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative follow-up strategies for patients after potentially curative surgery for colorectal cancer at Christchurch Hospital.
    Simpson H; Jeffery M; Hickey B; Frizelle F; Frampton C
    N Z Med J; 2004 May; 117(1193):U873. PubMed ID: 15133523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic disparity in colonic cancer outcomes in New Zealand--biology or an access issue?
    Sammour T; Kahokehr A; Vather R; Connolly AB; Hill AG
    Colorectal Dis; 2010 Jul; 12(7 Online):e50-6. PubMed ID: 19674020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of colorectal cancer: what can we learn from the New Zealand Cancer Registry?
    Keating J; Pater P; Lolohea S; Wickremesekera K
    N Z Med J; 2003 May; 116(1174):U437. PubMed ID: 12766783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An audit of colon cancer data on the New Zealand Cancer Registry.
    Cunningham R; Sarfati D; Hill S; Kenwright D
    N Z Med J; 2008 Aug; 121(1279):46-56. PubMed ID: 18709047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
    Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
    Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Young age influences treatment but not outcome of colon cancer.
    Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delays in the assessment and management of primary lung cancers in South Auckland.
    Sood JD; Wong C; Bevan R; Veale A; Sivakumaran P
    N Z Med J; 2009 May; 122(1294):42-50. PubMed ID: 19465946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial.
    Sadahiro S; Suzuki T; Ishikawa K; Yasuda S; Tajima T; Makuuchi H; Saitoh T; Murayama C
    Cancer; 2004 Feb; 100(3):590-7. PubMed ID: 14745877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients.
    Rulyak SJ; Lieberman DA; Wagner EH; Mandelson MT
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):470-6; quiz 407. PubMed ID: 17270502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for stage C colonic cancer in a multidisciplinary setting.
    Chapuis PH; Bokey EL; Clarke S; Beale P; Dent OF
    ANZ J Surg; 2009 Oct; 79(10):685-92. PubMed ID: 19878161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.